VEGFA and cataract: Advancements in cataract surgery have facilitated the cost-effective and successful treatment of cataracts [3], and the advent of anti-vascular endothelial growth factor (VEGF) agents has dramatically improved the outcome of neovascular AMD (nAMD) treatment [4,5].